Published in Hepatology on May 01, 1996
Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol (2013) 1.15
The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm (2006) 1.09
Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol (2014) 1.03
Reduced stents and stent-grafts for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation. Semin Intervent Radiol (2005) 0.91
Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol (2014) 0.89
High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation. Liver Transpl (2013) 0.83
Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites. J Korean Med Sci (2014) 0.82
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment. J Gastroenterol (2014) 0.81
Nutrition in the management of cirrhosis and its neurological complications. J Clin Exp Hepatol (2013) 0.81
Changes in nutritional status after liver transplantation. World J Gastroenterol (2014) 0.81
Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol (2016) 0.81
Nutritional evaluation in cirrhosis: Emphasis on the phase angle. World J Hepatol (2016) 0.80
Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view. Hepatol Int (2014) 0.79
Nutritional status and liver transplantation. J Clin Exp Hepatol (2012) 0.79
Hepatic encephalopathy therapy: An overview. World J Gastrointest Pharmacol Ther (2010) 0.78
Treatment to improve nutrition and functional capacity evaluation in liver transplant candidates. Curr Treat Options Gastroenterol (2014) 0.78
Systemic abnormalities in liver disease. World J Gastroenterol (2009) 0.78
The optimal cut-off value of the preoperative prognostic nutritional index for the survival differs according to the TNM stage in hepatocellular carcinoma. Surg Today (2017) 0.78
Hepatology - Guidelines on Parenteral Nutrition, Chapter 16. Ger Med Sci (2009) 0.76
Sarcopenia and liver transplant: The relevance of too little muscle mass. World J Gastroenterol (2015) 0.76
Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications. J Clin Exp Hepatol (2015) 0.76
Nutritional status in non-alcoholic sub-clinical porto-systemic encephalopathy. World J Gastroenterol (1998) 0.76
Handgrip Strength as an Important Bed Side Tool to Assess Malnutrition in Patient with Liver Disease. J Clin Exp Hepatol (2016) 0.75
Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. World J Gastroenterol (2010) 0.75
Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis. Hepatol Res (2012) 0.75
Effect of psoas muscle mass after endoscopic therapy for patients with esophageal varices. Medicine (Baltimore) (2017) 0.75
Assessment of body composition using dual energy x-ray absorptiometry in patients with liver cirrhosis: comparison with anthropometry. Korean J Intern Med (1999) 0.75
Nutritional care in hospitalized patients with chronic liver disease. World J Gastroenterol (2015) 0.75
Usefulness of the immunological rapid urease test for detection of Helicobacter pylori in patients who are reluctant to undergo endoscopic biopsies. Dig Dis Sci (2006) 0.75
Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol (2000) 2.42
ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr (2006) 2.11
T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood (2000) 1.94
Clinical nutrition practice in Italian Gastroenterology Units. Dig Liver Dis (2001) 1.42
Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection. J Pediatr (1999) 1.41
Increased energy expenditure in cirrhotic patients with hepatocellular carcinoma. Nutrition (1992) 1.39
Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. AIDS (1998) 1.28
Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology (1998) 1.18
Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study. Dig Dis Sci (1982) 0.99
Ipsilateral activation of the unaffected motor cortex in patients with hemiparetic stroke. Clin Neurophysiol (2000) 0.97
Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology (1999) 0.91
Glucose intolerance in liver cirrhosis. Metabolism (1982) 0.91
Ongoing prothrombotic state in the portal circulation of cirrhotic patients. Thromb Haemost (1997) 0.89
Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? A case report. Dig Liver Dis (2003) 0.89
The treatment of hepatic encephalopathy. Metab Brain Dis (2007) 0.88
Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transplant Proc (2005) 0.88
Basal energy production rate and substrate use in stable cirrhotic patients. Hepatology (1990) 0.88
Rapid measurement of isolated cardiac muscle cell length using a line-scan camera. IEEE Trans Biomed Eng (1987) 0.87
Optimal nutritional indexes in chronic liver disease. JPEN J Parenter Enteral Nutr (1987) 0.86
A scanning electron microscopic study of liver microcirculation disarrangement in experimental rat cirrhosis. Hepatology (1993) 0.86
Clinical practice guidelines for the management of cirrhotic patients with ascites. Committee on Ascites of the Italian Association for the Study of the Liver. Ital J Gastroenterol Hepatol (1999) 0.86
Circadian rhythmicity of plasma amino acid variations in healthy subjects. Recenti Prog Med (1989) 0.85
The hepatic microcirculation in experimental cirrhosis. A scanning electron microscopy study of microcorrosion casts. Scanning Microsc (1991) 0.85
Carbon tetrachloride-induced experimental cirrhosis in the rat: a reappraisal of the model. Eur Surg Res (1989) 0.84
Effect of glucose and/or branched chain amino acid infusion on plasma amino acid imbalance in chronic liver failure. JPEN J Parenter Enteral Nutr (1982) 0.84
Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients. Hepatology (1999) 0.84
Liver metabolic zonation and hepatic microcirculation in carbon tetrachloride-induced experimental cirrhosis. Dig Dis Sci (1997) 0.83
A comparison of skinfold anthropometry and dual-energy X-ray absorptiometry for the evaluation of body fat in cirrhotic patients. Clin Nutr (1999) 0.82
Effect of sodium benzoate on blood ammonia response to oral glutamine challenge in cirrhotic patients: a note of caution. Am J Gastroenterol (2000) 0.81
Malabsorption and nutritional abnormalities in patients with liver cirrhosis. Ital J Gastroenterol (1990) 0.81
Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy. Dig Dis Sci (1982) 0.81
Impaired hepatic handling and processing of lysophosphatidylcholine in rats with liver cirrhosis. Gastroenterology (1991) 0.79
Zinc and other trace elements in liver cirrhosis. Ital J Gastroenterol (1992) 0.79
Total and individual free fatty acid concentrations in liver cirrhosis. Metabolism (1984) 0.78
Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members. Ital J Gastroenterol Hepatol (1998) 0.78
Increased nonoxidative glucose metabolism in idiopathic reactive hypoglycemia. Metabolism (1996) 0.78
Resistance to insulin suppression of plasma free fatty acids in liver cirrhosis. J Endocrinol Invest (1990) 0.78
Zinc, ammonia, and Helicobacter pylori infection in liver cirrhosis. Dig Liver Dis (2000) 0.77
Nonabsorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other? Hepatology (1990) 0.77
Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation. Am J Gastroenterol (1999) 0.77
Insulin and glucagon levels in fulminant hepatic failure in man. Dig Dis Sci (1991) 0.77
Intractable hepatic encephalopathy after tips with polytetrafluoroethylene-covered stent-graft. Scand J Gastroenterol (2003) 0.76
Plasma tryptophan levels and anorexia in liver cirrhosis. Int J Eat Disord (1997) 0.76
The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis. J Clin Gastroenterol (1992) 0.76
Normal behaviour of circulatory parameters during exercise. Reference values for heart rate and systemic blood pressure. The ECCIS Project data. Epidemiologia e Clinica della Cardiopatia Ischemica Silente. G Ital Cardiol (1995) 0.76
Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluid. Hepatology (1987) 0.76
Intravascular hemolysis and transjugular intrahepatic portosystemic stent shunt. J Hepatol (1994) 0.76
Zinc supplementation in experimental liver cirrhosis: a morphological, structural and ultrastructural study. Int J Exp Pathol (1993) 0.75
First and second generation non absorbable disaccharides in the treatment of hepatic encephalopathy. Ital J Gastroenterol (1990) 0.75
Fatty acid composition of adipose tissue in patients with chronic liver disease. J Hepatol (1986) 0.75
The fluorescence of porcelain. Anesth Analg (1966) 0.75
Clotting activation after transjugular intrahepatic portosystemic stent shunt. Thromb Haemost (1999) 0.75
Composition of free fatty acids and adipose tissue triglycerides in portacaval shunted rats. Eur Surg Res (1987) 0.75
Simultaneous radioenzymatic determination of phenylethylamine, phenylethanolamine, tyramine and octopamine in plasma of patients with hepatic encephalopathy. Clin Biochem (1981) 0.75
[Gamma-aminobutyric acid (GABA) in the pathogenesis of hepatic encephalopathy]. Recenti Prog Med (1987) 0.75
Prevalence of chronic liver disease in northern Italy. Hepatology (1996) 0.75
Nutritional status in liver cirrhosis. Ital J Gastroenterol (1994) 0.75
[Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F]. Clin Ter (2010) 0.75
Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients. J Investig Med (1998) 0.75
[Pathogenesis of hepatic coma]. Recenti Prog Med (1981) 0.75
[Transjugular intrahepatic porto-systemic shunt (TIPS): indications and results]. Radiol Med (1994) 0.75
Is the blood-brain barrier really intact in portal-systemic encephalopathy? Lancet (1981) 0.75
Aminoacid imbalance and malnutrition in liver cirrhosis. Clin Nutr (1985) 0.75